Entrada Therapeutics, Inc. (TRDA) — Analyst estimates
Consensus analyst estimates for Entrada Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 9.25M | -0.92 | 1 |
| 2027 | 3.72M | -0.93 | 1 |
| 2028 | 687.5K | -1.11 | 2 |
| 2029 | 3.20M | -0.8 | 1 |
| 2030 | 9.90M | -0.6 | 1 |
Consensus analyst estimates by fiscal year.